moderna covid - Search News

News

Moderna to cut 10% of global workforce

Reuters on MSN · 21h

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by robust Spring COVID booster demand and aggressive cost cuts. The company also lowered its 2025 sales forecast to $1.

CNBC on MSN · 1d

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by the end of the year.

Fox Business on MSN · 1d

Moderna plans to slash 10% of workforce as COVID shot sales slow

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.

Pfizer, Moderna and BioNTech

Fast Company · 16h

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna’s patents at London’s Court of Appeal.

Reuters on MSN · 22h

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal. Last year, the High Cou

MarketWatch · 21h

Moderna Says U.K. Court Rules in Favor of its EP'949 Patent, Affirms Infringement by Pfizer and BioNTech

Moderna said a court ruled in favor of one of its patents and that it was infringed on by a competing vaccine. The biotechnology company on Friday said the U.K. Court of Appeal upheld the validity of its EP'949 patent.

19h

Moderna falls as cost-cutting fails to appease investors

Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the ...

15hon MSN

Moderna cuts sales forecast on UK revenue delay, shares fall

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, ...

14h

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

20h

Moderna lays off 500 in latest cost-cutting move

The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine ...

1d

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

1don MSN

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

21hon MSN

Moderna Logs Sales Beat Despite Declining Vaccine Demand

Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening ...

3d

Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results